LIXTE Biotechnology Holdings (NASDAQ: LIXT) is sponsoring the inaugural Good Health: Mind, Body & Soul Summit, an invitation-only event scheduled for Feb. 19 at Morehouse College in Atlanta. The summit, inspired by the music and legacy of De La Soul, brings together leaders in health, culture, science, and community to advance health equity for Black men and families. The program is rooted in De La Soul’s song “Good Health,” written after the passing of founding member David Jolicoeur (Trugoy the Dove).
Developed in collaboration with Blacksmith holdings, the summit reflects De La Soul’s evolution from musical pioneers to wellness advocates. Discussions will cover cancer, heart disease, mental health, addiction, sleep, relationships, and intergenerational wellness. LIXTE said the summit aligns with its mission as a clinical-stage pharmaceutical company advancing cancer care through its first-in-class oncology compound LB-100 and its European research subsidiary, LIORA, while creating a space to connect scientific innovation with communities most impacted by health disparities.
LIXTE’s lead compound, LB-100, is a PP2A inhibitor that has demonstrated tolerability in cancer patients at doses associated with anti-cancer activity. Based on published preclinical data available at www.lixte.com, LB-100 has the potential to enhance chemotherapies and immunotherapies. Proof-of-concept clinical trials are currently in progress for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company’s approach is covered by a comprehensive patent portfolio.
The sponsorship underscores LIXTE’s commitment to addressing health disparities. By participating in the summit, LIXTE aims to foster dialogue between researchers and communities that face disproportionate cancer burdens. The event is by invitation only, emphasizing targeted engagement with leaders who can drive change.
For more details on the press release, visit https://ibn.fm/0kkqK. Updates on LIXTE are available in the company’s newsroom at https://ibn.fm/LIXT.
